Roope A. Kallionpää

1.2k total citations
38 papers, 737 citations indexed

About

Roope A. Kallionpää is a scholar working on Neurology, Rheumatology and Epidemiology. According to data from OpenAlex, Roope A. Kallionpää has authored 38 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Neurology, 15 papers in Rheumatology and 12 papers in Epidemiology. Recurrent topics in Roope A. Kallionpää's work include Neurofibromatosis and Schwannoma Cases (27 papers), Soft tissue tumor case studies (13 papers) and Meningioma and schwannoma management (9 papers). Roope A. Kallionpää is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (27 papers), Soft tissue tumor case studies (13 papers) and Meningioma and schwannoma management (9 papers). Roope A. Kallionpää collaborates with scholars based in Finland, Sweden and Germany. Roope A. Kallionpää's co-authors include Juha Peltonen, Sirkku Peltonen, Elina Uusitalo, Minna Pöyhönen, Jussi Leppävirta, Janne Pitkäniemi, Matti Rantanen, Heli Ylä‐Outinen, Vincent M. Riccardi and ­Eero Pukkala and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

Roope A. Kallionpää

34 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roope A. Kallionpää Finland 14 551 196 187 154 103 38 737
Kimberly Jett Canada 10 411 0.7× 156 0.8× 150 0.8× 122 0.8× 101 1.0× 15 605
K Pulaski United States 8 395 0.7× 287 1.5× 147 0.8× 72 0.5× 102 1.0× 8 697
Stéphane Goutagny France 14 664 1.2× 628 3.2× 101 0.5× 105 0.7× 128 1.2× 34 930
Philippe Petiot France 13 408 0.7× 78 0.4× 55 0.3× 52 0.3× 159 1.5× 26 681
Dan X. Cai United States 13 331 0.6× 313 1.6× 69 0.4× 69 0.4× 278 2.7× 17 743
Geneviève Legault Canada 9 455 0.8× 206 1.1× 36 0.2× 112 0.7× 206 2.0× 19 733
P Mennonna Italy 15 312 0.6× 227 1.2× 116 0.6× 76 0.5× 102 1.0× 49 582
Patrice C. Abell-Aleff United States 10 207 0.4× 190 1.0× 57 0.3× 56 0.4× 145 1.4× 14 500
Rossella Gulli Italy 14 88 0.2× 60 0.3× 134 0.7× 39 0.3× 180 1.7× 21 676
Stephen G. Romansky United States 11 73 0.1× 60 0.3× 81 0.4× 103 0.7× 133 1.3× 23 420

Countries citing papers authored by Roope A. Kallionpää

Since Specialization
Citations

This map shows the geographic impact of Roope A. Kallionpää's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roope A. Kallionpää with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roope A. Kallionpää more than expected).

Fields of papers citing papers by Roope A. Kallionpää

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roope A. Kallionpää. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roope A. Kallionpää. The network helps show where Roope A. Kallionpää may publish in the future.

Co-authorship network of co-authors of Roope A. Kallionpää

This figure shows the co-authorship network connecting the top 25 collaborators of Roope A. Kallionpää. A scholar is included among the top collaborators of Roope A. Kallionpää based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roope A. Kallionpää. Roope A. Kallionpää is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kallionpää, Roope A., et al.. (2025). Pregnancy and the Risk for Cancer in Neurofibromatosis 1. Genes Chromosomes and Cancer. 64(2). e70017–e70017.
2.
Reinhold, V N, Roope A. Kallionpää, Kari Auranen, et al.. (2024). Hospital Visits Associated With Oral Infections in Patients With Neurofibromatosis Type 1: A Register‐Based Analysis. American Journal of Medical Genetics Part A. 197(2). e63887–e63887. 2 indexed citations
3.
Peltonen, Sirkku, et al.. (2024). 250 Patients with Darier disease have an increased risk of keratinocyte carcinoma. Journal of Investigative Dermatology. 144(12). S271–S271.
4.
Gillstedt, Martin, et al.. (2024). Patients with Darier disease have an increased risk of keratinocyte carcinoma: a Swedish registry-based nationwide cohort study. Orphanet Journal of Rare Diseases. 19(1). 463–463.
5.
Kallionpää, Roope A., Edvard Johansson, Petri Böckerman, Juha Peltonen, & Sirkku Peltonen. (2023). The contribution of morbidity and unemployment for the reduced labor market participation of individuals with neurofibromatosis 1 in Finland. European Journal of Human Genetics. 32(1). 83–90. 5 indexed citations
6.
Ylä‐Outinen, Heli, Roope A. Kallionpää, Kari Auranen, et al.. (2023). Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes. Molecular Genetics & Genomic Medicine. 12(1). e2346–e2346. 1 indexed citations
7.
Kallionpää, Roope A., Sirkku Peltonen, Elnaz Fazeli, et al.. (2023). Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1. Laboratory Investigation. 104(1). 100285–100285. 2 indexed citations
8.
Kallionpää, Roope A., Riikka Huovinen, Sirkku Peltonen, & Juha Peltonen. (2023). 486P The influence of NF1 germline and somatic mutations on breast cancer patient survival. Annals of Oncology. 34. S386–S386. 1 indexed citations
9.
Riihilä, Pilvi, et al.. (2022). 466 Cancer-associated fibroblast activation predicts progression, metastasis and prognosis of cutaneous squamous cell carcinoma. Journal of Investigative Dermatology. 142(12). S261–S261. 1 indexed citations
10.
Johansson, Edvard, Roope A. Kallionpää, Petri Böckerman, Juha Peltonen, & Sirkku Peltonen. (2020). A rare disease and education: Neurofibromatosis type 1 decreases educational attainment. Clinical Genetics. 99(4). 529–539. 16 indexed citations
11.
Ylä‐Outinen, Heli, et al.. (2019). Intestinal tumors in neurofibromatosis 1 with special reference to fatal gastrointestinal stromal tumors (GIST). Molecular Genetics & Genomic Medicine. 7(9). e927–e927. 17 indexed citations
12.
Wang, Xia, Roope A. Kallionpää, Patrick R. Gonzales, et al.. (2018). Germline and Somatic NF1 Alterations Are Linked to Increased HER2 Expression in Breast Cancer. Cancer Prevention Research. 11(10). 655–664. 3 indexed citations
13.
Leppävirta, Jussi, Roope A. Kallionpää, Elina Uusitalo, et al.. (2018). Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study. Orphanet Journal of Rare Diseases. 13(1). 5–5. 21 indexed citations
14.
15.
Kallionpää, Roope A., Jukka Huttunen, Terhi Huttunen, et al.. (2017). Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage. PLoS ONE. 12(6). e0178711–e0178711. 7 indexed citations
16.
Kallionpää, Roope A., Elina Uusitalo, Jussi Leppävirta, et al.. (2017). Prevalence of neurofibromatosis type 1 in the Finnish population. Genetics in Medicine. 20(9). 1082–1086. 105 indexed citations
17.
Leppävirta, Jussi, et al.. (2017). 008 Congenital anomalies in neurofibromatosis 1: A retrospective register-based total population study. Journal of Investigative Dermatology. 137(10). S194–S194. 3 indexed citations
18.
Uusitalo, Elina, Roope A. Kallionpää, Samu Kurki, et al.. (2016). Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors. British Journal of Cancer. 116(2). 211–217. 54 indexed citations
19.
Kallionpää, Roope A., Susanne Bäck, Mirkka Sarparanta, et al.. (2014). Synthesis and biological evaluation of novel 123I-labeled 4-(4-iodophenyl)butanoyl-l-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo. European Journal of Medicinal Chemistry. 79. 436–445. 2 indexed citations
20.
Weisell, Janne, Can Hekim, Roope A. Kallionpää, et al.. (2013). Pseudopeptides with a centrally positioned alkene-based disulphide bridge mimetic stimulate kallikrein-related peptidase 3 activity. MedChemComm. 4(3). 549–553. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimberly Jett Breakdown of academic impact, for papers by K Pulaski Breakdown of academic impact, for papers by Stéphane Goutagny Breakdown of academic impact, for papers by Philippe Petiot Breakdown of academic impact, for papers by Dan X. Cai Breakdown of academic impact, for papers by Geneviève Legault Breakdown of academic impact, for papers by P Mennonna Breakdown of academic impact, for papers by Patrice C. Abell-Aleff Breakdown of academic impact, for papers by Rossella Gulli Breakdown of academic impact, for papers by Stephen G. Romansky
Rankless by CCL
2026